Hinge Health, Inc. (HNGE) Stock Forecast & Price Target
Hinge Health, Inc. · NYSE
$92.79+0.42 (+0.45%)
15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 15 firms covering Hinge Health, Inc, 14 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets range widely, $59.00 to $125.00 (about 2.1x), a sign of real disagreement on valuation. The average target of $94.73 sits 2% above the current $92.79. The rating mix has stayed broadly stable, with Buy-side ratings easing from 16 to 14 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.69 next quarter toward $3.13 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS15 ratings
Strong Buy
Strong Buy00%
Buy1493%
Hold17%
Sell00%
Strong Sell00%
Based on 15 analysts giving stock ratings to Hinge Health, Inc.
As of Sep, 14 of 15 firms rate HNGE a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
HNGE EPS & revenue forecast
EPS · NEXT QUARTER
$0.69
Range $0.62 – $0.89 · 12 analysts · +40% YoY
Next period, 12 analysts expect Hinge Health, Inc. to earn $0.69 a share (range $0.62 – $0.89), versus $0.49 a year earlier. Full-year consensus is $2.43, growing to $3.13 the year after.
REVENUE · NEXT QUARTER
$239.5M
Range $236.9M – $247.6M · 12 analysts · +40% YoY
Revenue is expected to reach $239.5M (range $236.9M – $247.6M), +40.3% year-over-year. Full-year consensus is $859.3M, rising to $1.1B next year.
Top analysts covering Hinge Health, Inc.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on HNGE.
#1
Brian Peterson
Raymond James · Rank #407
Buy
$80.00-13.8% to target
Overall win rate
28%
+ Follow
#2
Scott Schoenhaus
Keybanc · Rank #413
Buy
$125.00+34.7% to target
Overall win rate
30%
+ Follow
#3
Ryan MacDonald
Needham · Rank #457
Buy
$97.00+4.5% to target
Overall win rate
18%
+ Follow
#4
Saket Kalia
Barclays
Buy
$100.00+7.8% to target
Coverage
—
+ Follow
#5
Richard Close
Canaccord Genuity
Buy
$105.00+13.2% to target
Coverage
—
+ Follow
HNGE stock forecast FAQ
What is HNGE's average 12-month price target?+
The 15 analysts with a live target average $94.73 for Hinge Health, Inc. over the next 12 months, ranging from a $125.00 high to a $59.00 low.
Is HNGE stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 15 analyst ratings, 14 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for HNGE?+
The Street-high target is $125.00 (Keybanc), and the Street-low is $59.00 (Freedom Capital Markets). The average of all 15 active targets is $94.73.
How many Wall Street analysts cover HNGE?+
15 analysts have an active rating on Hinge Health, Inc., and 15 firms carry a live 12-month price target.
Who is the most accurate analyst covering HNGE?+
Among analysts who currently cover HNGE, Brian Peterson of Raymond James has the strongest overall Quantellect track record (Rank #407). Their current call is Buy with a $80.00 target.
What is Hinge Health, Inc.'s projected EPS for next quarter?+
The consensus estimate is $0.69 per share (range $0.62 – $0.89) across 12 analysts. Full-year EPS is projected at $2.43, rising to $3.13 the following year.
How much revenue is Hinge Health, Inc. expected to report next quarter?+
Consensus revenue is $239.5M (range $236.9M – $247.6M). Full-year revenue is projected at $859.3M, growing to $1.1B next year.
Have analysts been upgrading or downgrading HNGE lately?+
As of Sep, 14 of 15 firms rate HNGE a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their HNGE calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
